Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{4891bd91ca62439db9e359cc57cb8d7e,

title = "Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate",

author = "Zhe Li and Zhu, \{Yu ting\} and Min Xiang and Qiu, \{Jun lan\} and Luo, \{Shou qing\} and Fang Lin",

year = "2021",

month = apr,

doi = "10.1038/s41401-020-0445-z",

language = "English",

volume = "42",

pages = "624--632",

journal = "Acta Pharmacologica Sinica",

issn = "1671-4083",

publisher = "Springer Nature",

number = "4",

}

TY - JOUR

T1 - Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate

AU - Li, Zhe

AU - Zhu, Yu ting

AU - Xiang, Min

AU - Qiu, Jun lan

AU - Luo, Shou qing

AU - Lin, Fang

PY - 2021/4

Y1 - 2021/4

U2 - 10.1038/s41401-020-0445-z

DO - 10.1038/s41401-020-0445-z

M3 - Article

SN - 1671-4083

VL - 42

SP - 624

EP - 632

JO - Acta Pharmacologica Sinica

JF - Acta Pharmacologica Sinica

IS - 4

ER -